Managing plasma cell leukemia
- 1 January 2007
- journal article
- editorial
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 48 (1), 5-6
- https://doi.org/10.1080/10428190600972527
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Primary plasma cell leukemia: Report of 17 new cases treated with autologous or allogeneic stem‐cell transplantation and review of the literatureAmerican Journal of Hematology, 2005
- Diagnosis of plasma cell leukaemia: findings of the UK NEQAS for Leucocyte Immunophenotyping schemeInternational Journal of Laboratory Hematology, 2004
- Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemiaAnnals of Hematology, 2002
- Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique HématologiqueBlood, 2001
- NONSECRETORY MYELOMA, IMMUNOGLOBULIN D MYELOMA, AND PLASMA CELL LEUKEMIAHematology/Oncology Clinics of North America, 1999
- The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myelomaLeukemia, 1998
- Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literatureBone Marrow Transplantation, 1997